FDA Aims To Invigorate Sluggish Drug-Labeling Overhaul

By Jeff Overley (February 5, 2013, 6:22 PM EST) -- Citing disappointing progress on improved prescription-drug labeling, the U.S. Food and Drug Administration said Tuesday that it was looking at providing the pharmaceutical industry with assistance to update drugs' safety information.

The agency is responding to a requirement that all new drugs approved after June 30, 2001, comply with new standards intended to make labels easier to read and more focused on the most important warnings about a drug's risks. Despite that rule, as well as efforts to encourage voluntary labeling updates for older drugs, only 15 percent of all prescription medicines abide by the new framework, according to the FDA....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!